The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease

BACKGROUND : Previously, the inhibition of coronary restenosis with Abciximab (ReoPro(®))-coated stent in a porcine model was reported. ReoPro(®) inhibits platelet aggregation, the proliferation of vascular smooth muscle cells and the inflammatory reaction. METHODS : A prospective randomized trial w...

Full description

Saved in:
Bibliographic Details
Published in:Korean J Intern Med
Main Authors: Kim, Weon, Jeong, Myung Ho, Hong, Young Joon, Lee, Seng Hyun, Park, Woo Seok, Kim, Ju Han, Kim, In Soo, Choi, Myung Ja, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Cho, Dong Lyun, Kim, Hoon, Kang, Jung Chaee
Format: Artigo
Language:Inglês
Published: Korean Association of Internal Medicine 2004
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531572/
https://ncbi.nlm.nih.gov/pubmed/15683110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2004.19.4.220
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items